Skip to main content
OpenTrials
Completed

NCT Number: NCT00139438

Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038)

The purpose of this study is to assess the impact of disease management interventions on percent receiving a bone densitometry test and percent appropriately prescribed a medication for osteoporosis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Members of the Horizon Blue Cross Blue Shield of New Jersey who are at risk for osteoporosis based on age (women age 65 or older, men and women age 45 or older who have a history of fragility fracture or have a history of taking oral glucocorticoids over 3 months).

Exclusion criteria

  • Individuals who are not members of Horizon Blue Cross Blue Shield of New Jersey and who otherwise do not meet the inclusion criteria.

Treatment and study plan

Disease Management Assessment

Behavioral

Primary outcomes

  1. A composite measure of bone mineral density (BMD) testing and/or osteoporosis medications prescriptions.

Secondary outcomes

  1. BMD testing, osteoporosis medication prescriptions, fracture

Sponsors and collaborators

Lead sponsor

Merck Sharp & Dohme LLC

Industry

Registry information

Official study title

Improving Management of Patients at High Risk for Osteoporotic Fractures

Important dates

Study start
2004
Primary completion
2005
Study completion
2005
First posted
Aug 31, 2005
Registry last updated
Apr 22, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.